Ali Choucair

4.3k total citations · 3 hit papers
40 papers, 3.0k citations indexed

About

Ali Choucair is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ali Choucair has authored 40 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 17 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Ali Choucair's work include Glioma Diagnosis and Treatment (29 papers), Brain Metastases and Treatment (14 papers) and Cancer-related cognitive impairment studies (5 papers). Ali Choucair is often cited by papers focused on Glioma Diagnosis and Treatment (29 papers), Brain Metastases and Treatment (14 papers) and Cancer-related cognitive impairment studies (5 papers). Ali Choucair collaborates with scholars based in United States, Canada and United Kingdom. Ali Choucair's co-authors include Minesh P. Mehta, Pamela Silver, Victor A. Levin, Rachel Hess, Bryce B. Reeve, Thomas E. Elliott, Claire Snyder, Joanne Greenhalgh, Maria Santana and Neil K. Aaronson and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Oncogene.

In The Last Decade

Ali Choucair

38 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

2013 616 citations Paul D. Brown, S. Pugh et al. Neuro-Oncology profile →
Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations

2011 593 citations Ali Choucair et al. profile →
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas

2011 401 citations Martin J. van den Bent, David Schiff et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ali Choucair United States	19	1.6k	1.2k	642	539	425	40	3.0k
Mark G. Malkin United States	29	1.8k 1.1×	1.2k 1.0×	627 1.0×	476 0.9×	414 1.0×	71	3.2k
Johan Menten Belgium	32	1.6k 1.0×	1.0k 0.8×	359 0.6×	518 1.0×	244 0.6×	100	3.7k
Linda Dirven Netherlands	31	1.5k 0.9×	808 0.7×	630 1.0×	346 0.6×	286 0.7×	179	3.3k
Lisa R. Rogers United States	30	1.3k 0.8×	1.3k 1.1×	586 0.9×	1.0k 1.9×	453 1.1×	103	4.0k
Terrence L. Cascino United States	29	1.7k 1.0×	1.3k 1.1×	472 0.7×	592 1.1×	345 0.8×	48	3.6k
Tanya Surawicz United States	20	888 0.5×	736 0.6×	1.0k 1.6×	698 1.3×	399 0.9×	39	3.4k
Ibrahim Qaddoumi United States	33	1.4k 0.9×	884 0.7×	688 1.1×	515 1.0×	601 1.4×	161	3.5k
Katharine J. Drummond Australia	29	1.2k 0.7×	583 0.5×	271 0.4×	527 1.0×	403 0.9×	136	2.4k
Sarah Jefferies United Kingdom	32	922 0.6×	1.3k 1.1×	771 1.2×	451 0.8×	538 1.3×	122	3.8k
Bjørn Henning Grønberg Norway	27	867 0.5×	1.3k 1.1×	1.2k 1.9×	471 0.9×	509 1.2×	111	3.1k

Countries citing papers authored by Ali Choucair

Since Specialization

Citations

This map shows the geographic impact of Ali Choucair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Choucair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Choucair more than expected).

Fields of papers citing papers by Ali Choucair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Choucair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Choucair. The network helps show where Ali Choucair may publish in the future.

Co-authorship network of co-authors of Ali Choucair

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Choucair. A scholar is included among the top collaborators of Ali Choucair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Choucair. Ali Choucair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Choucair, Ali, Soleilmane Omarjee, Julien Jacquemetton, et al.. (2019). The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer. Oncogene. 38(21). 4015–4027. 38 indexed citations

Wefel, Jeffrey S., Stephanie L. Pugh, Ali Choucair, et al.. (2019). NCOG-01. NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS. Neuro-Oncology. 21(Supplement_6). vi158–vi159. 5 indexed citations

Choucair, Ali, et al.. (2018). Nivolumab Induced Auto-immune Encephalitis (P5.395). Neurology. 90(15_supplement).

Laack, Nadia N., Stephanie L. Pugh, Paul D. Brown, et al.. (2018). The association of health-related quality of life and cognitive function in patients receiving memantine for the prevention of cognitive dysfunction during whole-brain radiotherapy. Neuro-Oncology Practice. 6(4). 274–282. 14 indexed citations

Choucair, Ali, et al.. (2018). Ipilimumab Induced Auto-immune Hypophysitis (P5.413). Neurology. 90(15_supplement).

Avila, Edward K., Marc C. Chamberlain, David Schiff, et al.. (2016). Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Neuro-Oncology. 19(1). 12–21. 88 indexed citations

Khan, Nadeem, et al.. (2016). Trigeminal Ganglioneuroma: A Rare Case of Trigeminal Neuralgia Caused by Cerebellopontine Angle Tumor. World Neurosurgery. 99. 811.e7–811.e10. 7 indexed citations

Shields, Lisa B. E. & Ali Choucair. (2014). Management of Low-Grade Gliomas: A Review of Patient-Perceived Quality of Life and Neurocognitive Outcome. World Neurosurgery. 82(1-2). e299–e309. 36 indexed citations

Brown, Paul D., S. Pugh, Nadia N. Laack, et al.. (2013). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro-Oncology. 15(10). 1429–1437. 616 indexed citations breakdown →

10.

Shields, Lisa B. E., et al.. (2013). Quality of life measures as a preliminary clinical indicator in patients with primary brain tumors. Surgical Neurology International. 4(1). 48–48. 7 indexed citations

11.

Chakravarti, Arnab, Meihua Wang, H. Ian Robins, et al.. (2012). RTOG 0211: A Phase 1/2 Study of Radiation Therapy With Concurrent Gefitinib for Newly Diagnosed Glioblastoma Patients. International Journal of Radiation Oncology*Biology*Physics. 85(5). 1206–1211. 122 indexed citations

12.

Choucair, Ali. (2011). Prognostic value of H-MLH1 after adjusting for RPA class in GBM patients. Frontiers in Bioscience-Elite. E3(3). 1182–1191. 2 indexed citations

13.

Bent, Martin J. van den, David Schiff, M. J. B. Taphoorn, et al.. (2011). Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. The Lancet Oncology. 12(6). 583–593. 401 indexed citations breakdown →

14.

Robins, H. Ian, Minhee Won, Wendy Seiferheld, et al.. (2006). Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-00211. Neuro-Oncology. 8(1). 47–52. 48 indexed citations

15.

Cardinale, Robert M., Minhee Won, Ali Choucair, et al.. (2006). A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. International Journal of Radiation Oncology*Biology*Physics. 65(5). 1422–1428. 76 indexed citations

16.

Chang, Susan M., Wendy Seiferheld, Walter J. Curran, et al.. (2004). Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors. International Journal of Radiation Oncology*Biology*Physics. 59(4). 1122–1126. 17 indexed citations

17.

Mehta, Minesh P., Dennis E. Bullard, Geoffrey Barger, et al.. (2001). Radiation Therapy Oncology Group. Research Plan 2002-2006. Brain Tumor Committee.. PubMed. 51(3 Suppl 2). 11–8. 1 indexed citations

18.

Choucair, Ali, et al.. (1997). Quality of life and neuropsychological evaluation for patients with malignant astrocytomas: RTOG 91-14. International Journal of Radiation Oncology*Biology*Physics. 38(1). 9–20. 34 indexed citations

19.

Gutin, Philip H., Steven A. Leibel, William M. Wara, et al.. (1987). Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. Journal of neurosurgery. 67(6). 864–873. 181 indexed citations

20.

Power, Scott, Ali Choucair, & Graham Palmer. (1975). Is lysine 79 a ligand for iron hexacyanides bound to cytochrome C?. Biochemical and Biophysical Research Communications. 66(1). 103–107. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact